LabCorp acquired Medical Neurogenetics (MNG) Laboratories
On March 1, 2019, MNG Laboratories (mnglabs.com) became part of LabCorp. MNG is an internationally recognized clinical diagnostic leader that specializes in next generation sequencing (NGS) and complex biochemical testing for neurology. MNG is located in Atlanta, GA, and has more than 15 years of neurogenetic experience. MNG’s team-based approach to data interpretation provides actionable results on the variants that cause or are likely to cause disease. MNG Laboratories delivers results that make a difference for patients and their families.
In addition to individual genes and gene panels, MNG’s test menu also provides advanced genetic testing options, including whole genome sequencing, whole exome sequencing, mitochondrial DNA sequencing, and RNA “Transcriptome” sequencing. MNG also has extensive expertise in biochemical genetics for testing inborn errors of metabolism and neurometabolic disorders.
The addition of MNG to the LabCorp network of laboratories enhances and expands LabCorp’s capabilities in the important areas of neurology and neurogenetics. Through LabCorp’s growing Partners in Clinical Neuroscience program, this acquisition further supports our mission to improve health and improve lives.